about
Fascin-1, ezrin and paxillin contribute to the malignant progression and are predictors of clinical prognosis in laryngeal squamous cell carcinoma.Hsa-miR-301a-3p Acts as an Oncogene in Laryngeal Squamous Cell Carcinoma via Target Regulation of Smad4Aurora-A modulates MMP-2 expression via AKT/NF-κB pathway in esophageal squamous cell carcinoma cells.Identification and characterization of CD133+CD44+ cancer stem cells from human laryngeal squamous cell carcinoma cell lines.Analysis of gene expression profiling variations induced by hsa‑miR‑145‑5p‑overexpression in laryngeal squamous cell carcinoma cell line Tu‑177.MicroRNA-204-5p inhibits invasion and metastasis of laryngeal squamous cell carcinoma by suppressing forkhead box C1.FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma.Primary laryngeal cancer-derived miR-193b induces interleukin-10-expression monocytes.Inhibition of autophagy-potentiated chemosensitivity to cisplatin in laryngeal cancer Hep-2 cells.Potential key molecular correlations in laryngeal squamous cell carcinoma revealed by integrated analysis of mRNA, miRNA and lncRNA microarray profiles.Expression of DNA topoisomerase II-α: Clinical significance in laryngeal carcinoma.Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2.The macro-evolutionary events in esophageal squamous cell carcinoma.IQGAP1 silencing suppresses the malignant characteristics of laryngeal squamous cell carcinoma cells.Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1Enhanced endosomal escape by photothermal activation for improved small interfering RNA delivery and antitumor effect.Cancer-derived matrix metalloproteinase-9 contributes to tumor toleranceWhole-Transcriptome Analysis of CD133+CD144+ Cancer Stem Cells Derived from Human Laryngeal Squamous Cell Carcinoma CellsHigh TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCCEffect of HPV Infection on the Occurrence and Development of Laryngeal Cancer: A ReviewLncRNA REG1CP promotes tumorigenesis through an enhancer complex to recruit FANCJ helicase for REG3A transcriptionMass Spectrometric Analysis Identifies AIMP1 and LTA4H as FSCN1-Binding Proteins in Laryngeal Squamous Cell CarcinomaMass spectrometry-based proteomic analysis of FSCN1-interacting proteins in laryngeal squamous cell carcinoma cellsmiR-424-5p Promotes Proliferation, Migration and Invasion of Laryngeal Squamous Cell CarcinomaAlloDriver: a method for the identification and analysis of cancer driver targetsAssessment of tumor-associated immune cells in laryngeal squamous cell carcinomaIdentification of miR-145-5p-Centered Competing Endogenous RNA Network in Laryngeal Squamous Cell CarcinomaCircular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/PBX3 axis
P50
Q34500644-F3EAE664-D830-4EE5-95A6-0332B04CC8B3Q36275017-5AC73A10-8182-4EAD-B843-30D2683E1D03Q37020076-3300E466-3816-4F21-B2D9-9EEBBE1B590AQ37676008-B71D7491-381D-4298-967C-F0C12CFFBE46Q38604521-4FB9637A-C04D-49A7-A3DF-8042CE87A62CQ38640499-F15C6249-94F0-483F-B3B9-729972BFAA38Q38794665-F558E72D-8E11-4990-A418-62323AAB09D5Q38927744-C5804CA9-0BF9-40DF-800C-B61C34264B8DQ39318385-79B744CA-24D5-48D4-8586-2B2036DB34C8Q39450189-52DAD5F2-721F-47AA-BFE1-839961B24EFBQ42865558-02C0F20D-F0A0-4988-B75B-1EA7F524BE5EQ47154327-5F02E179-A7D5-455D-A2A7-B3F24AB1B58BQ49948446-AB1B6DFE-507F-4FD6-AF9F-29C55CCFA492Q50529105-F708E763-5EE6-4866-BC35-809E068A2A8FQ57821175-51849028-15E9-4FBA-88B0-C44D88235A35Q64924379-6DA2B9C5-B3CB-4ED0-AF08-37D4E58A0338Q84744532-F8C2A0E3-C5E4-4E17-94A5-CD0234BB2F81Q89291673-595FB74D-BAC5-47A0-869D-5DEA601AA676Q89293167-26B02874-56E9-452C-81C4-47BC4B9940C3Q90136444-57844496-2FE8-40DF-8393-E76C7E62CB03Q91451646-CAD24A16-C475-4E48-8AC6-FC8A2AE46AF1Q91737499-9A0DC08A-A882-4532-96E9-00DA715D66B1Q91822314-F279768A-A3C9-4762-9F83-C51EC59379FEQ91829030-F33FA311-C9E6-4827-9A26-66578973FBF5Q91870342-A38AEB01-B442-4BC1-A3FF-4E259ED71126Q92209314-F43B31CF-502C-4D68-9299-D2DD062863BBQ92557475-DF4294E6-653B-41E8-9B73-EBB3BCDF0122Q96122501-CE8DA0B3-A0F5-4E2D-8994-C3EB4F5D97D2
P50
description
researcher (ORCID 0000-0001-7836-2851)
@en
name
Wei Gao
@en
type
label
Wei Gao
@en
prefLabel
Wei Gao
@en
P108
P31
P496
0000-0001-7836-2851